ESR1 and breast cancer: Since different immune microenvironments have been described between BRCA WT and BRCA-mutated BC [21], we next evaluated the immunological landscape of our 3 different groups of eBC even within ER + /HER2- tumors (Fig. 2C and Additional file 7: supplemental figure 6C (S6C)).